Amy Peacock
Biographic Data
| ID | 4439284 |
|---|---|
| NAME | Amy Peacock |
| GIVEN NAMES | Amy |
| FAMILY NAME | Peacock |
| SIGNATURE | PEACOCK A |
| AFFILIATIONS | National Drug and Alcohol Research Centre UNSW Sydney Sydney Australia |
| ORCID | 0000-0002-5705-2026 |
| VERIFIED | Yes |
| TOTAL WORKS | 74 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 74 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Rates and Clinical Characteristics of Self‐Administered Fatal Ketamine‐Related Poisoning in Australia, 2000–2025
An Observational Study of Off‐Premise Alcoholic Beverage Pricing Over Time in New South Wales, Australia
Illicit Alcohol in Victorian Off‐Licence Retailers: A Preliminary Observational Study
Using Mandatory Sales Reports to Monitor Same‐Day Alcohol Delivery Trends in New South Wales
The Emergence of Novel Benzodiazepines in Australia, Evidence, Alerts, Clinical Management and Harm Reduction—A Narrative Review
The Need to Revitalise Drug Use Monitoring to Keep Pace With a More Dynamic, Digitally Enabled and Globally Connected Drug Market
Globalisation, developments in information technology, and social and demographic changes are profoundly impacting the modern world [1]. They have also resulted in an illicit drug market that is more dynamic, complex and globally connected [2]. Drug consumption patterns are rapidly changing, with synthetic drugs, controlled psychoactive substances and poly substance use all playing a greater role [3]. These developments are impacting both the nat…
Price of Nitazenes for Sale on Cryptomarkets and Surface Web Shops
Factors Associated With Opioid Agonist Treatment Engagement and Harm Reduction Service Use: Findings From the New South Wales Opioid Dependence Survey
Incorporating experiential reports provided by people who use drugs into drug-related early warning systems: Benefits, risks principles and approaches
Dynamic shifts in crystal methamphetamine and heroin price and purity in metropolitan Melbourne and rural Victoria, Australia, 2009-2020
Overall declines in both crystal methamphetamine and heroin purity-adjusted prices in Victoria suggests that, by 2019, people who purchased these drugs received more drug for a given purchase than in previous years. These changes closely match trends seen in some key harms such as opioid overdose
Co-design of the Australian Prompt Response Network for a public-health focused intersectoral approach to information sharing on emerging drugs of concern
The rapid emergence of new psychoactive substances (NPS) and other emerging drugs of concern presents a significant global public health challenge, necessitating agile and interconnected drug information systems to identify and communicate risks. In Australia, responses have traditionally been localized, lacking a nationally coordinated system to rapidly share information about emerging drug threats. The National Center for Clinical Research on E…
Safe beats down under: Investigating the support of drug checking at a regional festival in the Northern Territory, Australia
Background In the context of Australian music festivals, including those in the Northern Territory (NT), drug-related harms persist. This study focused on gathering local insights into drug-related behaviours and attitudes, particularly regarding drug checking, among NT festival attendees.Methods In May 2022, attendees (aged 16+) at a single-day multi-genre music festival in the NT were surveyed onsite about their drug use and harm reduction beha…
Nitrous Oxide Sourcing, Use and Harms: Insights From Australians Who Use Ecstasy/MDMA and Other Illicit Stimulants
Changes in Drug‐Induced Hospitalisations and Deaths During the First Year of the Covid ‐19 Pandemic in Australia
Creating Safer Injecting Practices Through Community‐Led Harm Reduction: Lessons From People Who Use Steroids for the Alcohol and Other Drug Sector
Risk communication about high‐dose MDMA: Impact of a hypothetical drug alert on future MDMA use
Assessing the Early Impact of the Change in the Kava Importation Policy in Australia
The Australian Government launched the kava pilot program to ease import regulations on kava, aiming to strengthen cultural and economic ties between Australia and Pacific Island countries. Implemented in two phases, personal importation in 2019 and commercial importation in 2021, the program was accompanied by a concurrent evaluation. The evaluation examined the health, social, cultural and economic impacts of the pilot program on the Australian…
Excess Alcohol‐Induced Hospitalisations and Deaths During the First Year of the Covid ‐19 Pandemic in Australia
Changes in the rates and characteristics of gamma hydroxybutyrate (GHB)‐related death in Australia, 2001–2023
Trends and psychosocial correlates of same day polysubstance use among people who inject drugs in Australia, 2012-2022
Same day polysubstance use has remained relatively common among this sample over time, although the typology has changed. Collectively, our findings point to diverse drug use patterns among people who inject drugs and reiterate the need for a range of harm reduction, treatment, and support options
From environmental disasters to emerging drugs; a framework to understand, map and assess drug-related early warning systems
Unregulated drug markets are fast expanding and increasingly mediated through digital technologies. In a context of drug prohibition, the composition, potency and effects of substances are not guaranteed which can expose people to potentially fatal risks. There are pronounced concerns about the harms posed by substances such as synthetic opioids like fentanyl and nitazenes. The coordinated activities of stakeholders who attempt to identify, prepa…
Individual-level harm reduction intervention coverage among people in Australia who inject drugs
Individual-level needle/syringe and OAT coverage among people who inject drugs in Australian capital cities is high relative to targets, but there are gaps in the implementation of THN. Despite high syringe coverage, a notable minority reported needle/syringe reuse
Emergence of deaths due to nitazene toxicity in Australia
Nitazenes are highly potent opioids, classed as new psychoactive substances (NPS), that were never registered for clinical use due to concerns regarding their toxicity. As with all opioids, the main mechanism of toxicity is respiratory depression. In recent years, there have been reports from Australia and elsewhere of hospitalisations for nitazene toxicity [1]. To date, no study has examined deaths due to nitazene toxicity in Australia. To exami…
Information acquisition and dissemination among a sample of people who inject drugs in Australia
Stigma, and factors associated with experiencing stigma, while visiting health‐care services among samples of people who use illegal drugs in Australia
No prominent works on this page.
Energy drink ingredients. Contribution of caffeine and taurine to performance outcomes
Self-reported physiological and psychological side-effects of an acute alcohol and energy drink dose
Awareness of energy drink intake guidelines and associated consumption practices: A cross-sectional study
Australia is considered to have the most stringent regulatory approach to EDs internationally. However, advisory statements are not associated with greater awareness and compliance with intake guidelines. Failure to comply with standards for efficacious product labelling, and absence of broader education regarding guidelines, needs to be addressed
Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulation
A systematic review of injecting-related injury and disease among people who inject drugs
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: A systematic review
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review
Trends in Pieds use among male clients of needle–syringe programs in Queensland, Australia; 2007–2015
I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances
Motivations for new psychoactive substance use among regular psychostimulant users in Australia
Global statistics on alcohol, tobacco and illicit drug use: 2017 Status Report
Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs
The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis
Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis
Illicit drug use and harms in Australia in the context of Covid ‐19 and associated restrictions: Anticipated consequences and initial responses
Illicit drug use and harms can significantly and rapidly change with market disruptions. The study of major historical events (e.g. illicit drug use in the context of the 2008 Global Financial Crisis 1) can inform predictions of the effects of major market disruptions. However, the COVID-19 pandemic is an unparalleled event in modern times, precipitating widespread government interventions to close borders and restrict social interactions. These …
Patterns and correlates of prescribed and non‐prescribed pregabalin use among a sample of people who inject drugs in Australia
Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis
Frequency of injecting among people who inject drugs: A systematic review and meta-analysis
Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence
Patterns of smoking and injecting methamphetamine and their association with health and social outcomes
Trends in cocaine use, markets and harms in Australia, 2003–2019
Covid ‐19 vaccination among people who inject drugs: Leaving no one behind
Timely rollout and widespread uptake of safe and effective vaccines will be necessary to reduce mortality, improve health outcomes, restore societal well-being and inspire economic recovery from the coronavirus disease (COVID-19) pandemic. Unprecedented efforts to accelerate vaccine development have resulted in the emergency or expedited approval of several COVID-19 vaccines [1]. The Australian Government has secured access to both the Pfizer and…
Trends in treatment episodes for methamphetamine smoking and injecting in Australia, 2003–2019
Combining transdermal and breath alcohol assessments, real‐time drink logs and retrospective self‐reports to measure alcohol consumption and intoxication across a multi‐day music festival
Medicine (49 works) · Opioid Use Disorder Treatment (29 works) · Psychiatry (26 works) · HIV, Drug Use, Sexual Risk (25 works) · Internal Medicine (25 works) · Environmental health (24 works) · Drug (21 works) · Forensic Toxicology and Drug Analysis (21 works) · Psychology (19 works) · Substance Abuse Treatment and Outcomes (15 works)